Is IO Biotech (NASDAQ:IOBT) In A Good Position To Deliver On Growth Plans?
yahoo.com
news
2022-10-15 12:37:03

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly.

Given this risk, we thought we'd take a look at whether IO Biotech (NASDAQ:IOBT) shareholders should be worried about its cash burn.
